Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.80    0.00 (0.00%)
Bid:
27.80
Ask:
29.80
Spread: 2.00 (7.194%)
Market Cap: £76.28m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Interim Management Statement

9 Oct 2014 12:30

RNS Number : 8996T
Maven Income and Growth VCT 5 PLC
09 October 2014
Β 

ο»Ώ

Maven Income and Growth VCT 5 PLC (the Company)

Β 

Interim Management Statement - quarter ended 31 August 2014

Β 

This Interim Management Statement, for the quarter ended 31 August 2014, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 September 2014 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

Β 

1.

Financial highlights

Β 

Β· Net asset value (NAV)1 of 40.18p per share at 31 August 2014, after payment of the interim dividend, compared to 42.18p per share at 31 May 2014;

Β· NAV total return2 of 67.63p at 31 August 2014, compared to 68.83p at 31 May 2014; and

Β· Interim dividend of 0.80p per share in respect of the year ending 30 November 2014, paid on 29 August 2014.

Β 

1The NAV is unaudited and reflects the closing bid price of quoted securities at 31 August 2014. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 31 May 2014, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

Β 

2.

Investments and disposals

Β 

During the quarter ended 31 August 2014, a net amount of Β£1,559,085 was invested in five unlisted companies and Β£442,984 was invested in one listed company. In the same period, proceeds of Β£2,000,000 were realised from the sale of short-dated UK treasury bills; and the realisation of four holdings in unlisted companies generated aggregate proceeds of Β£697,505 against a cost of Β£505,291. In addition, the full or partial sale of five AIM quoted investments generated aggregate proceeds of Β£717,027 against a total cost of Β£461,986.

Β 

3.

Recent developments

Β 

Between 1 September 2014 and the date of this Statement, Β£529,368 was invested in two unlisted companies and a net amount of Β£1,991,863 was invested in short-dated UK treasury bills. The full or partial disposals of two AIM quoted investments generated proceeds of Β£505,468 against a cost of Β£132,024.

Β 

Β 

Other than as described above, and changes in the value of investments quoted on regulated markets, the Board is not aware of any material events during the period from 1 June 2014 to 31 August 2014, or in the period from 1 September 2014 to the date of this announcement, which would have had a material impact on the financial position of the Company.

Β 

Issued on behalf of the Board

Β 

Maven Capital Partners UK LLP

Secretary

Β 

9Β October 2014

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSFKLFBZBFLFBV
Date   Source Headline
16th Apr 201411:49 amRNSDirector Declaration
7th Apr 20144:19 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 201411:32 amRNSIssue of Equity
18th Mar 20147:00 amRNSOffer for Subscription - Supplementary Prospectus
3rd Mar 20144:13 pmRNSAnnual Financial Report
13th Feb 201410:57 amRNSDirector/PDMR Shareholding
13th Feb 201410:55 amRNSDirector/PDMR Shareholding
13th Feb 201410:47 amRNSDirector/PDMR Shareholding
10th Feb 20146:04 pmRNSOffer for Subscription - Supplementary Prospectus
5th Feb 20144:22 pmRNSIssue of Equity
3rd Feb 20145:23 pmRNSStatement re NAV and Offer for Subscription (Repla
27th Jan 20145:00 pmRNSStatement re NAV, Dividend and Offer
27th Nov 20132:07 pmRNSResult of General Meeting
24th Oct 20136:09 pmRNSOffer for Subscription
15th Oct 20135:10 pmRNSTransaction in Own Shares
11th Oct 20135:12 pmRNSInterim Management Statement
11th Oct 201312:18 pmRNSDirectorate Change
10th Oct 201311:02 amRNSNet Asset Value(s)
9th Oct 201311:09 amRNSNet Asset Value(s)
8th Oct 20131:49 pmRNSNet Asset Value(s)
7th Oct 201312:35 pmRNSNet Asset Value(s)
4th Oct 20132:12 pmRNSNet Asset Value(s)
3rd Oct 20132:36 pmRNSNet Asset Value(s)
2nd Oct 201312:21 pmRNSNet Asset Value(s)
1st Oct 201312:27 pmRNSNet Asset Value(s)
30th Sep 20132:43 pmRNSNet Asset Value(s)
27th Sep 201312:04 pmRNSNet Asset Value(s)
26th Sep 201311:57 amRNSNet Asset Value(s)
25th Sep 201312:22 pmRNSNet Asset Value(s)
25th Sep 201311:39 amRNSStatement re Proposed Joint Fund Raising
24th Sep 201311:52 amRNSNet Asset Value(s)
23rd Sep 201311:47 amRNSNet Asset Value(s)
20th Sep 20132:15 pmRNSNet Asset Value(s)
19th Sep 20131:05 pmRNSNet Asset Value(s)
18th Sep 201310:16 amRNSNet Asset Value(s)
17th Sep 201310:38 amRNSNet Asset Value(s)
16th Sep 201311:35 amRNSNet Asset Value(s)
13th Sep 201311:25 amRNSNet Asset Value(s)
12th Sep 201311:09 amRNSNet Asset Value(s)
11th Sep 201312:26 pmRNSNet Asset Value(s)
10th Sep 201312:22 pmRNSNet Asset Value(s)
9th Sep 20131:41 pmRNSNet Asset Value(s)
6th Sep 201311:44 amRNSNet Asset Value(s)
5th Sep 20131:14 pmRNSDirector Declaration
5th Sep 201312:33 pmRNSNet Asset Value(s)
4th Sep 20131:37 pmRNSNet Asset Value(s)
3rd Sep 201310:50 amRNSNet Asset Value(s)
2nd Sep 201311:17 amRNSNet Asset Value(s)
30th Aug 201312:30 pmRNSNet Asset Value(s)
29th Aug 201310:56 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.